Literature DB >> 9350737

Detection of rifampin resistance by single-strand conformation polymorphism analysis of cerebrospinal fluid of patients with tuberculosis of the central nervous system.

P Scarpellini1, S Braglia, A M Brambilla, M Dalessandro, P Cichero, A Gori, A Lazzarin.   

Abstract

Mutations in a 69-bp region of the rpoB gene of Mycobacterium tuberculosis are associated with rifampin resistance (Rif[r]). These have been detected with mycobacterial DNA extracted from bacterial suspensions or respiratory specimens that were acid-fast smear positive. We experimented with a strategy for the rapid detection of Rif(r) in cerebrospinal fluid (CSF) samples. The strategy involves the amplification of the 69-bp region of rpoB by means of PCR and the identification of nucleotide mutations by single-strand conformation polymorphism (SSCP) analysis of the amplification products. Sixty-five CSF specimens collected from 29 patients (19 patients were coinfected with human immunodeficiency virus) with culture or autopsy-confirmed (22 patients) or highly probable (7 patients) tuberculosis of the central nervous system (CNS-TB) were processed. Amplified products suitable for evaluation by SSCP analysis were obtained from 37 CSF specimens from 25 subjects (86.2%). PCR-SSCP of CSF correctly identified the rifampin susceptibility phenotype of isolates from all 17 patients for whom the results of susceptibility tests carried out with strains cultured from CSF or respiratory samples were available. Moreover, this assay revealed the rifampin susceptibility genotype of isolates from the eight patients (three patients with culture-confirmed CNS-TB and five patients in whom CNS-TB was highly probable) for whom no susceptibility test results were available; the PCR-SSCP data obtained for these patients were concordant with the outcome after a standard antituberculosis treatment. The evolution of a mutation in the rpoB gene was documented in a patient during the course of treatment. PCR-SSCP analysis of CSF seems to be an efficacious method of predicting Rif(r) and would reduce the time required for susceptibility testing from approximately 4 to 8 weeks to a few days.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350737      PMCID: PMC230065          DOI: 10.1128/jcm.35.11.2802-2806.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique.

Authors:  D A Caugant; P Sandven; J Eng; J T Jeque; T Tønjum
Journal:  Microb Drug Resist       Date:  1995       Impact factor: 3.431

3.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

4.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  Tuberculous meningitis.

Authors:  D H Kennedy; R J Fallon
Journal:  JAMA       Date:  1979-01-19       Impact factor: 56.272

Review 7.  Tuberculous meningitis.

Authors:  J M Leonard; R M Des Prez
Journal:  Infect Dis Clin North Am       Date:  1990-12       Impact factor: 5.982

8.  Molecular basis of rifampin resistance in Mycobacterium leprae.

Authors:  N Honore; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system.

Authors:  A H Kolk; A R Schuitema; S Kuijper; J van Leeuwen; P W Hermans; J D van Embden; R A Hartskeerl
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

10.  Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis.

Authors:  A Telenti; P Imboden; F Marchesi; T Schmidheini; T Bodmer
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

View more
  4 in total

1.  Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis.

Authors:  P Scarpellini; S Braglia; P Carrera; M Cedri; P Cichero; A Colombo; R Crucianelli; A Gori; M Ferrari; A Lazzarin
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil.

Authors:  A R Valim; M L Rossetti; M O Ribeiro; A Zaha
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

4.  Role of IS6110-targeted PCR, culture, biochemical, clinical, and immunological criteria for diagnosis of tuberculous meningitis.

Authors:  M Caws; S M Wilson; C Clough; F Drobniewski
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.